Are Everest Inds. latest results good or bad?

Oct 30 2025 07:41 PM IST
share
Share Via
Everest Industries' latest results are concerning, showing an 18.75% decline in net sales year-on-year and a net loss of ₹18.17 crores in Q2 FY26, indicating significant operational challenges and a reversal in profitability. The company's financial performance has deteriorated, raising liquidity concerns and necessitating urgent attention to restore profitability.
The latest financial results for Everest Industries indicate significant operational challenges. In the quarter ended September 2025, the company reported net sales of ₹306.16 crores, which reflects an 18.75% decline year-on-year from ₹376.82 crores in the same quarter of the previous year. This marks a substantial decrease compared to the previous quarter's sales of ₹500.72 crores, highlighting a severe contraction in revenue.
The company faced a net loss of ₹18.17 crores in Q2 FY26, a sharp deterioration from a profit of ₹1.63 crores in Q1 FY26. This represents a significant reversal in profitability, with operating margins turning negative at -2.94%, down from a positive margin of 3.27% in the prior quarter. The operational performance is further underscored by a negative operating profit before depreciation, interest, and tax (PBDIT) of ₹-9.01 crores, a stark contrast to the previous quarter's positive figure. Additionally, the financial metrics reveal a concerning trend in cash flow, with operating cash flow turning negative at ₹-90.00 crores for FY25, raising liquidity concerns. The company's average return on equity (ROE) over the last five years stands at 5.70%, which is below industry standards, and the latest ROE for FY25 has turned negative at -2.37%. The overall evaluation of Everest Industries has undergone an adjustment, reflecting the deteriorating financial performance and operational inefficiencies. The company is facing critical challenges that require immediate attention to restore profitability and improve its financial standing.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Everest Industries Ltd is Rated Strong Sell
Jan 23 2026 10:10 AM IST
share
Share Via
Everest Industries Ltd is Rated Strong Sell
Jan 12 2026 10:10 AM IST
share
Share Via
Everest Industries Ltd is Rated Strong Sell
Jan 01 2026 10:10 AM IST
share
Share Via
Why is Everest Industries Ltd falling/rising?
Dec 25 2025 02:02 AM IST
share
Share Via
Most Read
Saboo Sodium Chloro Ltd is Rated Sell
29 minutes ago
share
Share Via
Jenburkt Pharmaceuticals Ltd. is Rated Sell
29 minutes ago
share
Share Via
iStreet Network Ltd is Rated Sell
29 minutes ago
share
Share Via
Emmbi Industries Ltd is Rated Sell
29 minutes ago
share
Share Via
Cohance Lifesciences Ltd is Rated Sell
29 minutes ago
share
Share Via
Vivo Bio Tech Ltd. is Rated Strong Sell
29 minutes ago
share
Share Via